Skip to main content
Log in

“Programmed-cell-death”-Protein 1 (PD-1/CD279)

Funktion als negativer Kostimulator und Rolle bei nephrologischen Erkrankungen

Programmed cell death protein 1 (PD-1/CD279)

Its function as a negative costimulator and its role in nephrological diseases

  • Nephro molekular
  • Published:
Der Nephrologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Francisco LM, Sage PT, Sharpe AH (2010) The PD-1 pathway in tolerance and autoimmunity. Immunol Rev 236:219–242

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  2. Bertsias GK, Nakou M, Choulaki C et al (2009) Genetic, immunologic, and immunohistochemical analysis of the programmed death 1/programmed death ligand 1 pathway in human systemic lupus erythematosus. Arthritis Rheum 60:207–218

    Article  PubMed  CAS  Google Scholar 

  3. Dolff S, Quandt D, Feldkamp T et al (2014) Increased percentages of PD-1 on CD4+ T cells is associated with higher INF-gamma production and altered IL-17 production in patients with systemic lupus erythematosus. Scand J Rheumatol 43:307–313

    Article  PubMed  CAS  Google Scholar 

  4. Nishimura H, Nose M, Hiai H et al (1999) Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 11:141–151

    Article  PubMed  CAS  Google Scholar 

  5. Wilde B, Hua F, Dolff S et al (2012) Aberrant expression of the negative costimulator PD-1 on T cells in granulomatosis with polyangiitis. Rheumatology (Oxford) 51:1188–1197

    Article  CAS  Google Scholar 

  6. Metcalfe W, Anderson J, Trinh VA et al (2015) Anti-programmed cell death-1 (PD-1) monoclonal antibodies in treating advanced melanoma. Discov Med 19:393–401

    PubMed  Google Scholar 

  7. Demmers MW, Korevaar SS, Roemeling-van Rhijn M et al (2015) Human renal tubular epithelial cells suppress alloreactive T cell proliferation. Clin Exp Immunol 179:509–519

    Article  PubMed  CAS  Google Scholar 

  8. Starke A, Lindenmeyer MT, Segerer S et al (2010) Renal tubular PD-L1 (CD274) suppresses alloreactive human T-cell responses. Kidney Int 78:38–47

    Article  PubMed  CAS  Google Scholar 

  9. Reynolds J, Sando GS, Marsh OB et al (2012) Stimulation of the PD-1/PDL-1 T-cell co-inhibitory pathway is effective in treatment of experimental autoimmune glomerulonephritis. Nephrol Dial Transplant 27:1343–1350

    Article  PubMed  CAS  Google Scholar 

  10. Ooi JD, Li M, Kourkoutzelos K et al (2015) Programmed death 1 and its ligands do not limit experimental foreign antigen-induced immune complex glomerulonephritis. Nephrology (Carlton) 20:892–898

    Article  CAS  Google Scholar 

  11. Tanaka K, Albin MJ, Yuan X et al (2007) PDL1 is required for peripheral transplantation tolerance and protection from chronic allograft rejection. J Immunol 179:5204–5210

    Article  PubMed  CAS  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to B. Wilde.

Ethics declarations

Interessenkonflikt

B. Wilde hat Reisekostenunterstützung von Alexion, Chiesi, TEVA, Sanofi und Wyeth erhalten. J. Subburayalu gibt an, dass kein Interessenkonflikt besteht.

Additional information

Redaktion

O. Witzke, Essen

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Subburayalu, J., Wilde, B. “Programmed-cell-death”-Protein 1 (PD-1/CD279). Nephrologe 11, 70–72 (2016). https://doi.org/10.1007/s11560-015-0037-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11560-015-0037-y

Navigation